A detailed history of Morgan Stanley transactions in Bio N Tech Se stock. As of the latest transaction made, Morgan Stanley holds 1,147,797 shares of BNTX stock, worth $131 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,147,797
Previous 1,083,910 5.89%
Holding current value
$131 Million
Previous $100 Million 7.75%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

BUY
$80.36 - $102.87 $5.13 Million - $6.57 Million
63,887 Added 5.89%
1,147,797 $92.2 Million
Q2 2024

Aug 14, 2024

BUY
$80.36 - $102.87 $5.13 Million - $6.57 Million
63,887 Added 5.89%
1,147,797 $92.2 Million
Q1 2024

Oct 17, 2024

SELL
$88.96 - $112.35 $5.68 Million - $7.18 Million
-63,887 Reduced 5.57%
1,083,910 $100 Million
Q1 2024

Aug 16, 2024

BUY
$88.96 - $112.35 $40.5 Million - $51.2 Million
455,659 Added 72.53%
1,083,910 $100 Million
Q1 2024

May 15, 2024

BUY
$88.96 - $112.35 $40.5 Million - $51.2 Million
455,659 Added 72.53%
1,083,910 $100 Million
Q4 2023

Aug 16, 2024

SELL
$90.91 - $112.75 $47.2 Million - $58.6 Million
-519,546 Reduced 45.26%
628,251 $66.3 Million
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $4.32 Million - $5.36 Million
47,541 Added 8.19%
628,251 $66.3 Million
Q3 2023

Nov 15, 2023

BUY
$98.5 - $125.08 $1.03 Million - $1.31 Million
10,482 Added 1.84%
580,710 $63.1 Million
Q2 2023

Aug 14, 2023

SELL
$102.58 - $129.66 $39.8 Million - $50.3 Million
-388,280 Reduced 40.51%
570,228 $61.5 Million
Q1 2023

May 15, 2023

BUY
$122.57 - $153.67 $62.5 Million - $78.3 Million
509,637 Added 113.54%
958,508 $119 Million
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $12.8 Million - $20.1 Million
108,244 Added 31.78%
448,871 $67.4 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $8.42 Million - $12.1 Million
65,931 Added 24.0%
340,627 $45.9 Million
Q2 2022

Oct 27, 2022

SELL
$123.25 - $186.24 $2.58 Million - $3.9 Million
-20,965 Reduced 7.09%
274,696 $41 Million
Q2 2022

Aug 15, 2022

SELL
$123.25 - $186.24 $2.58 Million - $3.9 Million
-20,965 Reduced 7.09%
274,696 $41 Million
Q1 2022

Oct 27, 2022

BUY
$126.25 - $231.85 $2.65 Million - $4.86 Million
20,965 Added 7.63%
295,661 $50.4 Million
Q1 2022

May 13, 2022

BUY
$126.25 - $231.85 $1.18 Million - $2.17 Million
9,346 Added 3.26%
295,661 $50.4 Million
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $10.5 Million - $17.5 Million
-48,352 Reduced 14.45%
286,315 $73.8 Million
Q3 2021

Nov 15, 2021

BUY
$205.93 - $447.23 $68.9 Million - $150 Million
334,667 New
334,667 $91.4 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.